Tag - First Light Biosciences

First Light Diagnostics Receives FDA Clearance for its Rapid Clostridiodes difficile Test on the MultiPath® Analyzer

First Light Diagnostics is developing and commercializing breakthrough automated diagnostic products for rapidly detecting infections and determining optimal treatment. The company announced today that the US Food and Drug Administration (FDA) has cleared its SensiTox™ C. difficile Toxin Test along with its proprietary MultiPath Analyzer to be marketed in the US. Read more >>

First Light Diagnostics Appoints Joanne Spadoro as Chief Executive Officer

First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis of life-threatening antibiotic resistant infections, has named Joanne Spadoro, PhD as President and Chief Executive Officer (CEO). As the CEO of First Light Diagnostics, Dr. Spadoro will be responsible for leading the company through the development and commercialization phases of its novel pathogen identification and rapid antimicrobial susceptibility products. Read more >>

First Light Diagnostics Receives Additional Funding from the Biomedical Advanced Research and Development Authority (BARDA)

First Light Diagnostics, Inc., a developer of breakthrough automated products for the rapid diagnosis and treatment of life-threatening infections, today announced the authorization of a $4 million award from the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services. These funds will continue BARDA’s support of First Light Diagnostics’ proprietary MultiPath™ platform and a rapid ultrasensitive test to identify victims […]